Literature DB >> 34123921

Effect of COVID-19 on control of T1DM patients in Aseer region of Saudi Arabia.

Mohammad Ahmad Awwad Alqahtani1, Abdullah Othman Al Othman2, Amal Mohammed Alqahtani2, Abdullah Mohammed Ahmed AlQahtani3, Fatimah Abdullah Mohammad Asiri4, Alqahtani Mohammed Mesfer2, Sahar Dahman Alshehri5,6, Suliman H Al-Fifi5,6.   

Abstract

BACKGROUND: The novel corona virus disease, also known as COVID-19, has emerged as a major health concern globally. Its association with comorbid condition has increased its mortality. Diabetes mellitus (DM) is associated with increased risk of infection in comparison to general population. This risk is higher in type 1 DM that type 2 DM.
METHODS: A cross sectional study was done in T1DM patients in whom a structured questionnaire was administered after lockdown. Data regarding social demographical variables, Information regarding sugar levels, psychological effects, changes in weight, exercise habits and other variables were included in the validated, electronic questionnaire. Ethic approval was obtained from the Diabetic center Abha, study duration was from January-2020 to October-2020.
RESULTS: Out of 143 total patients (46.9%) were males while 53.1% were females. Mean ± S.D of age was obtained 29.6 ± 1.8. [Figure 1] depicted that 23% of the respondents were effected psychologically. [Figure 2] depicted that 80.4% used insulin as a treatment. [Figure 3] depicted that 8% of the respondents make an emergency visit to the health care centers for high rise in diabetes during lockdown.
CONCLUSION: COVID-19 and the lockdown affected the management of T1DM. It resulted in changes in lifestyle, compliance to medication, and psychological impact on the participant. Copyright:
© 2021 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  Covid-19; diabetes; lockdown; psychology; type 1

Year:  2021        PMID: 34123921      PMCID: PMC8144754          DOI: 10.4103/jfmpc.jfmpc_2333_20

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

The novel corona virus disease, also known as COVID-19, has emerged as a major health concern globally. Its association with comorbid condition has increased its mortality.[1] Diabetes mellitus (DM) is associated with increased risk of infection in comparison to general population. This risk is higher in type 1 DM that type 2 DM.[23] Moreover, DM is one of the leading causes of mortality in Covid-19 infected patient 3. However, in spite of high mortality rate with concurrent presence of Diabetes Mellitus and COVID-19, very few studies have been done comparing the mortality in children and adults with Type 1 DM 3. As per the guidelines of International Society for Pediatrics and Adolescent Diabetes (ISPAD) continuous monitoring and awareness towards diabetes has been emphasized in order to avoid the need for hospitalization.[34] Lockdown during COVID-19 forced the people to stay indoor resulting in reduced physical activity, alteration in dietary habit and psychological stress. All these factors play important roles in glucose control especially in Type I DM who are on insulin therapy. Moreover, unavailability to use healthcare services also affected the management of DM. Previous studies have reported both short-term and long-term negative effect on diabetic control during natural disasters mainly due to lack of healthcare facilities and unavailability of food.[5] Recently a study on 147 T1DM patients in Spain, who were on insulin therapy, reported no deleterious impact on glycemic control even after 5 weeks on lockdown imposed due to COVID-19.[6] Similarly, Bonora et al. conducted a study on 20 T1DM patients in Italy. They found a beneficiary effect in glycemic control in the first few weeks of the lockdown. This short term beneficial effect was due to reduced work load and possibility of adequate rest.[789] In a study done in the Kingdom of Saudi Arabia, it was found that although there was minimal psychological stress, the compliance in terms of medication and lifestyle modification was significantly reduced in diabetic patients due to the lockdown.[10] Therefore, in the absence of reliable data on the control of T1DM, poor compliance by the patientsl and increased risk for developing diabetes related complication during the current COVID-19 pandemic, this study was carried out to investigate the impact of COVID-19 induces lockdown on control of T1DM patients in Aseer region of Kingdom of Saudi Arabia.

Methods

A cross sectional study was done in T1DM patients in whom a structured questionnaire was administered after lockdown. Data regarding social demographical variables, Information regarding sugar levels, psychological effects, changes in weight, exercise habits and other variables were included in the validated, electronic questionnaire. Ethic approval was obtained from the Diabetic center Abha, August, 2020. Written consent was taken from all the participants, regarding their participation in the survey. Questionnaire was constructed by the panel of experts including diabetes experts, researchers and subject specialists, Cronbach alpha of the questionnaire was obtained to measure the internal consistency of the questionnaire. Data were entered in SPSS ver. 22 software for analysis. Descriptive statistics (mean, S.D, frequency and percentages) was obtained while inferential statistics was also computed Chi-square test was used to measure the significance differences among the variables. P value less than 0.05 was considered as a significant value.

Results

Out of 143 total patients (46.9%) were males while 53.1% were females. Mean ± S.D of age was obtained 29.6 ± 1.8 [Table 1]. Figure 1 depicted that 23% of the respondents were affected psychologically. Figure 2 depicted that 80.4% used insulin as a treatment. Figure 3 depicted that 8% of the respondents make an emergency visit to the health care centres for high rise in diabetes during lockdown. Table 2 showed that we have observed the significant difference between HBVA1c levels and type of hospitals (government and private hospitals) Figure 4 showed that 5% of the patients were died. Cronbach alpha of the questionnaire was 0.84.
Table 1

Descriptive statistics

FrequencyPercent
Gender
 Female7653.1
 Male6746.9
 Total143100.0
Education status
 Postgraduate74.9
 Secondary and lower5538.5
 University8156.6
 Total143100.0
Where to follow Diabetes?
 Government Hospitals11880.0
 Private Hospitals2520.0
 Total143100.0
Do you measure blood sugar level daily?
 No4531.5
 Yes9868.5
 Total143100.0
Figure 1

The psychological impact of the epidemic period on the rise in diabetes

Figure 2

Treatment type

Figure 3

Did you need an emergency visit due to high diabetes during the lockdown?

Table 2

Comparison between hospitals and HBVA1c level

Comparisons of Hospitals with respect to HBVA1C level

HBVA1C levelTotal

789<7>9
Institute
 Government Hospital
  Count050112829118
  % within institute0.0%42.4%9.3%23.7%24.6%100.0%
 Private hospital
  Count21026525
  % within institute8.0%40.0%8.0%24.0%20.0%100.0%
 Total
  Count260133434143
  % within institute1.4%42.0%9.1%23.8%23.8%100.0%

P=0.04

Figure 4

Status of severe patients

Descriptive statistics The psychological impact of the epidemic period on the rise in diabetes Treatment type Did you need an emergency visit due to high diabetes during the lockdown? Comparison between hospitals and HBVA1c level P=0.04 Status of severe patients

Discussion

In view of the global COVID-19 pandemic, lockdown was considered as an essential step required to slow down the spread of the virus. It prevented people from leaving their homes and forced them to stay indoors. This study was done on 143 type 1 diabetic patients to describe the impact of lockdown on their glycemic control. Type 1 DM is caused by deficiency of insulin which has adverse effect on glucose utilization. Therefore, good glycemic control is important to have a good immunity and prevent both short-term and long-term complications. The fear associated with COVID-19 and the lockdown affected thousands of people in their day to day life. Moreover, it also slowed down the economy. All these factors affected the quality of life and resulted in death of many who were suffering from chronic illness.[1110] Prolonged confinement at a particular place can have adverse psychological effects. In our study we have observed that COVID-19 had psychological impact on 23% of the respondents which was in line with a Danish study which should more greatly concerns about COVID-19 among female diabetics.[1213] In our study, although there was no difference with respect to psychological impact among males and females, the patients were distressed and worried about their diabetic control and felt lonely. They were also worried about COVID-19. This could be because DM was considered as a comorbid condition. There is no evidence to support that diabetic patients are susceptible to infection by COVID-19 but diabetic patients are believed to be at a higher risk of developing complication and studies have reported that concurrent presence of DM and COVID-19 is associated with higher mortality. This has been termed as Diabetes Distress.[1415] As the study group comprised of T1DM, the most common mode of glycemic control was subcutaneous injections of Insulin which was reported by 80.4% of the diabetics. Rest of the diabetics were either on dietary control or some other medication. Similar pattern of medication has been reported in other studies.[1116] Most of the patients preferred to visit government hospitals rather than private hospitals. This was due to factors such as free treatment and medication, consultation through telemedicine and setting up of dedicated clinic for management of diabetes. The findings of this study would help endocrinologist, physicians and health care policy makers to modify their treatment protocol during the pandemic to ensure good glycemic control.

Conclusion

COVID-19 and the lockdown affected the management of T1DM. It resulted in changes in lifestyle, compliance to medication, and psychological impact on the participant. It is also necessary to educate and council the patients regarding home management of DM. However, this study was done at a single center. In order to substantiate our findings more similar studies should be carried out various centers across the kingdom. Acknowledgement We acknowledge the efforts of Mr. Muhammad Abid Khan for data analysis and valued contribution.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  16 in total

1.  Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy.

Authors:  Ernesto Maddaloni; Lucia Coraggio; Silvia Pieralice; Angela Carlone; Paolo Pozzilli; Raffaella Buzzetti
Journal:  Diabetes Care       Date:  2020-06-05       Impact factor: 19.112

2.  No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes.

Authors:  Pilar Isabel Beato-Víbora
Journal:  Diabetes Technol Ther       Date:  2020-05-12       Impact factor: 6.118

Review 3.  Chronic diseases and natural hazards: impact of disasters on diabetic, renal, and cardiac patients.

Authors:  Andrew C Miller; Bonnie Arquilla
Journal:  Prehosp Disaster Med       Date:  2008 Mar-Apr       Impact factor: 2.040

4.  Coping with diabetes during the COVID - 19 lockdown in India: Results of an online pilot survey.

Authors:  Sukanya Nachimuthu; R Vijayalakshmi; M Sudha; Vijay Viswanathan
Journal:  Diabetes Metab Syndr       Date:  2020-05-11

5.  Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.

Authors:  Anjali Verma; Rajesh Rajput; Surender Verma; Vikas K B Balania; Babita Jangra
Journal:  Diabetes Metab Syndr       Date:  2020-07-13

Review 6.  The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.

Authors:  Hussin A Rothan; Siddappa N Byrareddy
Journal:  J Autoimmun       Date:  2020-02-26       Impact factor: 7.094

7.  Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.

Authors:  Xiaochen Li; Shuyun Xu; Muqing Yu; Ke Wang; Yu Tao; Ying Zhou; Jing Shi; Min Zhou; Bo Wu; Zhenyu Yang; Cong Zhang; Junqing Yue; Zhiguo Zhang; Harald Renz; Xiansheng Liu; Jungang Xie; Min Xie; Jianping Zhao
Journal:  J Allergy Clin Immunol       Date:  2020-04-12       Impact factor: 10.793

Review 8.  COVID-19 and diabetes: Knowledge in progress.

Authors:  Akhtar Hussain; Bishwajit Bhowmik; Nayla Cristina do Vale Moreira
Journal:  Diabetes Res Clin Pract       Date:  2020-04-09       Impact factor: 8.180

9.  COVID-19 and diabetes.

Authors:  R C W Ma; R I G Holt
Journal:  Diabet Med       Date:  2020-04-03       Impact factor: 4.213

10.  Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?

Authors:  L E Joensen; K P Madsen; L Holm; K A Nielsen; M H Rod; A A Petersen; N H Rod; I Willaing
Journal:  Diabet Med       Date:  2020-05-29       Impact factor: 4.213

View more
  2 in total

1.  The Experiences of People with Diabetes during COVID-19 Pandemic Lockdown.

Authors:  Modi Al-Moteri; Virginia Plummer; Hanan A M Youssef; Ruba W H Yaseen; Mohammed Al Malki; Ahmed AbdElbagy Ibrahim Elryah; Ahmed Al Karani
Journal:  Int J Environ Res Public Health       Date:  2021-12-29       Impact factor: 3.390

2.  COVID-19 Lockdown and Lifestyle Changes in Saudi Adults With Types 1 and 2 Diabetes.

Authors:  Nasser M Al-Daghri; Abeer A Almiman; Kaiser Wani; Malak N K Khattak; Naji J Aljohani; Hanan Alfawaz; Abdulaziz Al-Hameidi; Dara Aldisi; Ghadah Alkhaldi; Shaun Sabico
Journal:  Front Public Health       Date:  2022-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.